Sung-Wuk Kim
Founder at ImmunoMet Therapeutics, Inc.
Net worth: 38 M $ as of 30/04/2024
Profile
Sung-Wuk Kim is the founder of ImmunoMet Therapeutics, Inc. which was founded in 2015.
He currently holds the title of Chairman at ImmunoMet Therapeutics, Inc. Dr. Kim is also currently working as the Director at Korean Drug Research Association.
In the past, he held the position of President, Chief Executive Officer & Director at HANALL BIOPHARMA Co., Ltd.
from 2011 to 2014.
Dr. Kim also served as the Chief Executive Officer at Health Prime International LLC and as a Director at Bridge Biotherapeutics, Inc. Dr. Kim completed his undergraduate degree at Yonsei University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2023 | 1,469,702 ( 2.81% ) | 38 M $ | 30/04/2024 |
Sung-Wuk Kim active positions
| Companies | Position | Start |
|---|---|---|
| Korean Drug Research Association | Director/Board Member | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Founder | 01/11/2017 |
Former positions of Sung-Wuk Kim
| Companies | Position | End |
|---|---|---|
Health Prime International LLC
 Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Chief Executive Officer | - |
| BRIDGE BIOTHERAPEUTICS, INC. | Director/Board Member | - |
| HANALL BIOPHARMA CO., LTD. | Chief Executive Officer | - |
Training of Sung-Wuk Kim
| Yonsei University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HANALL BIOPHARMA CO., LTD. | Health Technology |
| BRIDGE BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Korean Drug Research Association | |
Health Prime International LLC
Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Commercial Services |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Sung-Wuk Kim
